Twist Bioscience will collaborate with Neogene Therapeutics to develop personalized oncologic chimeric antigen receptor T-cell therapies and T-cell-receptor therapies. As part of the deal, Twist will design a specialized TCR library that will be used to discover engineered TCRs for two specific cancer T-cell targets.
Twist, Neogene partner on personalized cancer therapies
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.